Literature DB >> 1327043

99mTc(V)-DMSA and 99mTc-MDP uptake and no 67Ga-citrate uptake in a case of primary pulmonary leiomyosarcoma.

H Ohta1, T Komibuchi, H Nishiyama, K Shizuki, Y Miyaki.   

Abstract

Tumor scintigraphy with 67Ga-citrate, 99mTc(V)-DMSA and 99mTc-MDP were performed on a patient with rare primary pulmonary leiomyosarcoma. While 67Ga-citrate accumulation to the tumor was not recognized, 99mTc(V)-DMSA and 99mTc-MDP scintigraphy showed relatively intense localization of the tracers in the lesion, and were very useful in suggesting the characteristics of the tumor.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1327043     DOI： 10.1007/bf03178312

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN： 0914-7187            Impact factor:   2.668


  6 in total

1.  Localization of radionuclide bone agent in a perigastric leiomyomatous tumor.

Authors:  W Small; W A Fajman
Journal:  Clin Nucl Med       Date:  1991-09       Impact factor: 7.794

2.  Primary leiomyosarcoma of the lung originating in an emphysematous bulla.

Authors:  P Stark; L Frood
Journal:  Rofo       Date:  1989-12

Review 3.  [Primary pulmonary leiomyosarcoma--a case report and a review of 68 cases in Japan].

Authors:  A Tatsumi; M Kitano; A Yamanaka; T Matsui; N Yamashita
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1987-09

4.  Gallium-67 citrate scintigraphy in the pre-operative evaluation of soft tissue tumors of the extremities.

Authors:  T Imaeda; M Seki; Y Sone; G Iinuma; M Kanematsu; R Mochizuki; S Takeuchi; Y Nishimoto; K Shimokawa
Journal:  Ann Nucl Med       Date:  1991-11       Impact factor: 2.668

Review 5.  Primary pulmonary sarcomas: etiology, clinical assessment and prognosis with a comparison to pulmonary carcinomas--a review of 41 cases and 394 other cases of the literature.

Authors:  C Gebauer
Journal:  Jpn J Surg       Date:  1982

6.  Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.

Authors:  H Ohta; K Endo; T Fujita; J Konishi; K Torizuka; K Horiuchi; A Yokoyama
Journal:  Nucl Med Commun       Date:  1988-02       Impact factor: 1.690
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.